[1]
Donoso, P. del R.Q., Briones, R.F.Z., Castro, C.P.M., Narváez, D.L.B., Velasco, S.A. and Jimenez, S.N.C. 2026. Impact of GLP-1 receptor agonists on cardiovascular risk reduction in patients with obesity without type 2 diabetes mellitus: a systematic review. International Journal of Research in Medical Sciences. 14, 5 (Apr. 2026), 2051–2057. DOI:https://doi.org/10.18203/2320-6012.ijrms20261347.